IN BRIEF: Kanabo signs supply agreement with PharmaCann Polska

Kanabo Group PLC - London-based medicinal cannabis firm that listed in February - Signs agreement ...

Alliance News 9 March, 2021 | 1:53PM
Email Form Facebook Twitter LinkedIn RSS

Kanabo Group PLC - London-based medicinal cannabis firm that listed in February - Signs agreement with PharmaCann Polska allowing PharmaCann to supply cartridges containing Kanabo's proprietary medicinal cannabis formulations for its VapePod inhalation device. Notes this is Kanabo's second key agreement directed towards establishing a European medicinal cannabis supply chain. Says the cartridges will be filled and prepared at PharmaCann's facility in North Macedonia.

"Following the increased fund-raise achieved at the [initial public offering], we are able to accelerate preparations for supply of medicinal cannabis products in addition to building our CBD Wellness business. I am delighted to work with PharmaCann which will enable us to provide medical cannabis vape products to thousands of patients safely and effectively using our medical grade VapePod device," says Kanabo Chief Executive Avihu Tamir.

Current stock price: 22.00 pence, up from 18.50p on February 16

By Zoe Wickens; zoewickens@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
Kanabo Group PLC 2.51 GBX -3.46 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.